Jerome Wong - Jun 17, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
InterimChief Financial Officer
Signature
/s/ Jerome Wong
Stock symbol
EKSO
Transactions as of
Jun 17, 2022
Transactions value $
$0
Form type
4
Date filed
6/22/2022, 06:17 PM
Next filing
Jul 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +83.3K +403.9% $0.00 104K Jun 17, 2022 Direct F1, F2, F3
holding EKSO Common Stock 3.21K Jun 17, 2022 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 The RSU grant was approved by the Board of Directors in a meeting held on May 25, 2022 in connection with the Reporting Person's appointment as the Company's interim Chief Financial Officer, effective from June 17, 2022.
F3 Represents the amount of RSUs equal to $150,000 divided by the closing price of the Company's stock on June 17, 2022 of $1.80. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of June 17, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the issuer as of each vesting date.